Geoff Lawton


Geoff has extensive experience in new medicine discovery across many therapeutic areas and is a co-inventor of a marketed drug (Cilazapril). He is a former Director of Chemistry at Roche UK, and Vice-president Chemistry and Preclinical Sciences within Roche Bioscience, Palo Alto, USA. He was the founding Research Director with Lectus Therapeutics building from start-up a drug discovery organisation; generating the team, facilities and project portfolio targeting the next generation of ion channel modulating medicines. Geoff provides scientific and strategic evaluation and advice as an independent consultant to a wide range of drug discovery organisations. Clients include large and small biopharma companies, CROs, VCs, academic groups and medical research charities. He is a founder of INMedD, a new medicines discovery social enterprise.